These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 34071499)

  • 41. Nutritional management in women with polycystic ovary syndrome: A review study.
    Faghfoori Z; Fazelian S; Shadnoush M; Goodarzi R
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S429-S432. PubMed ID: 28416368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.
    Barber TM; Dimitriadis GK; Andreou A; Franks S
    Clin Med (Lond); 2016 Jun; 16(3):262-6. PubMed ID: 27251917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Norman RJ; Teede HJ
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007506. PubMed ID: 21328294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials.
    Unfer V; Carlomagno G; Dante G; Facchinetti F
    Gynecol Endocrinol; 2012 Jul; 28(7):509-15. PubMed ID: 22296306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet.
    O'Connor A; Gibney J; Roche HM
    Proc Nutr Soc; 2010 Nov; 69(4):628-35. PubMed ID: 20696094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-sensitizing agents in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome.
    Seow KM; Chang YW; Chen KH; Juan CC; Huang CY; Lin LT; Tsui KH; Chen YJ; Lee WL; Wang PH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An isocaloric low glycemic index diet improves insulin sensitivity in women with polycystic ovary syndrome.
    Barr S; Reeves S; Sharp K; Jeanes YM
    J Acad Nutr Diet; 2013 Nov; 113(11):1523-1531. PubMed ID: 23999280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome.
    Pundir J; Charles D; Sabatini L; Hiam D; Jitpiriyaroj S; Teede H; Coomarasamy A; Moran L; Thangaratinam S
    Hum Reprod Update; 2019 Mar; 25(2):243-256. PubMed ID: 30608609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.
    Barber TM; Dimitriadis GK; Andreou A; Franks S
    Clin Med (Lond); 2015 Dec; 15 Suppl 6():s72-6. PubMed ID: 26634686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes.
    Ortiz-Flores AE; Luque-Ramírez M; Escobar-Morreale HF
    Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.